Abstract
The in vitro activity of flomoxef (6315-S) was determined and compared to that of different cephalosporins against 787 clinical isolates of staphylococci,Enterobacteriaceae and anaerobes. Flomoxef is similar in activity to latamoxef and cefotaxime againstEnterobacteriaceae, slightly more active than cephalothin and cefamandole against oxacillin-sensitive strains ofStaphylococcus aureus and minimally less active than cefamandole against oxacillin-resistant strains. Flomoxef showed similar or better activity than latamoxef and cefoxitin against most of the anaerobic species of medical importance.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Neu, H. C. Antibiotic inactivating enzymes and bacterial resistance. In: Lorian, V. (ed.): Antibiotics in laboratory medicine. Williams & Wilkins, Baltimore, 1986, p. 757–789.
Murakami, K., Nomura, K., Doi, M., Yoshida, T. Production of low affinity penicillin-binding protein by low- and high-resistance groups of methicillin-resistantStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1987, 31: 1307–1311.
Neu, H. C., Chin, N-X. In vitro activity andβ-lactamase stability of a new difluoro-oxacephem, 6315-S. Antimicrobial Agents and Chemotherapy 1986, 30: 638–644.
Murakami, K., Doi, M., Nomura, K., Nakamoto, S., Yoshida, T. 6315-S (flomoxef), a new oxacephem antibiotic: stability againstβ-lactamases and affinities for penicillin-binding proteins ofEscherichia coli andStaphylococcus aureus. Chemotherapy (Tokyo) 1987, 35, Supplement S 1: 108–120.
Yokota, T., Suzuki, E., Arai, K., Kato, N. A new oxacephem, 6315-S (flomoxef), its antibacterial activity toβ-lactamases, binding-affinity to penicillin-binding proteins, and synergy of bacterial effect with serum complement and cultured macrophages. Chemotherapy (Tokyo) 1987, 35, Supplement 1: 33–43.
Iyobe, S., Kubota, T., Mitsuhashi, S. In vitro and in vivo antibacterial activities of 6315-S (flomoxef). Chemotherapy (Tokyo) 1987, 35, Supplement 1: 22–32.
Nishino, T., Otsuki, M., Higashiyama, J., Yamashita, Y., Tanino, T. Bacteriological evaluation of 6315-S (flomoxef), a new oxacephem antibiotic. Chemotherapy (Tokyo) 1987, 35, Supplement 1: 57–75.
Sawa, K., Aoki, M., Kohno, H., Kobayashi, T., Watanabe, K., Ueno, K. In vitro and in vivo antibacterial activity of 6315-S (flomoxef) against anaerobic bacteria. Chemotherapy (Tokyo) 1987, 35, Supplement 1: 44–56.
Kamedy, Y., Nagata, H., Motokawa, K., Fukao, T., Nakamoto, S., Watanabe, Y., Yoshida, T. In vitro antibacterial activity of 6315-S (flomoxef), a new oxacephem antibiotic. Chemotherapy (Tokyo) 1987, 35, Supplement 1: 76–107.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ruckdeschel, G., Eder, W. Comparative in vitro activity of the new oxacephem antibiotic, flomoxef (6315-S). Eur. J. Clin. Microbiol. Infect. Dis. 7, 687–691 (1988). https://doi.org/10.1007/BF01964256
Issue Date:
DOI: https://doi.org/10.1007/BF01964256